Business Description
SynCore Biotechnology Co Ltd
ISIN : TW0004192000
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.36 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 3.32 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 38.88 | |||||
Beneish M-Score | 1.98 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.1 | |||||
3-Year EBITDA Growth Rate | 64.1 | |||||
3-Year EPS without NRI Growth Rate | 56.1 | |||||
3-Year FCF Growth Rate | 39 | |||||
3-Year Book Growth Rate | -19.4 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.65 | |||||
9-Day RSI | 41.21 | |||||
14-Day RSI | 41.52 | |||||
6-1 Month Momentum % | 8.99 | |||||
12-1 Month Momentum % | -16.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 15.33 | |||||
Quick Ratio | 14.96 | |||||
Cash Ratio | 12.83 | |||||
Days Inventory | 172.24 | |||||
Days Sales Outstanding | 34.97 | |||||
Days Payable | 49.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 5.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 9.41 | |||||
Operating Margin % | -101.79 | |||||
Net Margin % | -62.83 | |||||
FCF Margin % | -333.58 | |||||
ROE % | -5.26 | |||||
ROA % | -4.18 | |||||
ROIC % | -22.18 | |||||
3-Year ROIIC % | -113.73 | |||||
ROC (Joel Greenblatt) % | -51.44 | |||||
ROCE % | -5.15 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 57.01 | |||||
PB Ratio | 4.2 | |||||
Price-to-Tangible-Book | 4.91 | |||||
EV-to-EBIT | -79.51 | |||||
EV-to-EBITDA | 302.22 | |||||
EV-to-Revenue | 49.23 | |||||
EV-to-FCF | -15.14 | |||||
Price-to-Median-PS-Value | 0.23 | |||||
Price-to-Net-Current-Asset-Value | 5.36 | |||||
Price-to-Net-Cash | 6.52 | |||||
Earnings Yield (Greenblatt) % | -1.26 | |||||
FCF Yield % | -5.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
SynCore Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 23.426 | ||
EPS (TTM) (NT$) | -0.521 | ||
Beta | 0.28 | ||
Volatility % | 34.67 | ||
14-Day RSI | 41.52 | ||
14-Day ATR (NT$) | 0.706906 | ||
20-Day SMA (NT$) | 39.6625 | ||
12-1 Month Momentum % | -16.05 | ||
52-Week Range (NT$) | 34.55 - 57.8 | ||
Shares Outstanding (Mil) | 35.17 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SynCore Biotechnology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SynCore Biotechnology Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
SynCore Biotechnology Co Ltd Frequently Asked Questions
What is SynCore Biotechnology Co Ltd(ROCO:4192)'s stock price today?
When is next earnings date of SynCore Biotechnology Co Ltd(ROCO:4192)?
Does SynCore Biotechnology Co Ltd(ROCO:4192) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |